Lupin - Quaterly Results

27 Oct 2021 Evaluate
A decrease in the sales to Rs. 28701.70 millions was observed for the quarter ended September 2021. The sales stood at Rs. 30426.00 millions during the similar quarter previous year.The Net Loss for the quarter ended September 2021 is Rs. -13291.20 millions as compared to Net Profit of Rs. 3604.30 millions of corresponding quarter ended September 2020Operating profit Margin for the quarter ended September 2021 slipped to -13242.70% as compared to 6230.70% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 28701.70 30426.00 -5.67 61842.90 57376.80 7.78 110559.30 110256.60 0.27
Other Income 746.80 252.90 195.29 1263.60 593.00 113.09 1290.90 4751.90 -72.83
PBIDT -13242.70 6230.70 -312.54 -3347.20 12523.80 -126.73 21731.50 23828.00 -8.80
Interest 182.60 91.30 100.00 330.80 178.10 85.74 406.20 525.90 -22.76
PBDT -13425.30 6139.40 -318.67 -3678.00 12345.70 -129.79 21325.30 15710.00 35.74
Depreciation 1299.00 1256.00 3.42 2552.60 2507.40 1.80 5028.30 5187.50 -3.07
PBT -14724.30 4883.40 -401.52 -6230.60 9838.30 -163.33 16297.00 10522.50 54.88
TAX -1433.10 1279.10 -212.04 601.90 2598.20 -76.83 3710.80 3247.00 14.28
Deferred Tax 1760.30 -20.30 -8771.43 1729.70 -73.80 -2443.77 82.30 -373.50 -122.03
PAT -13291.20 3604.30 -468.76 -6832.50 7240.10 -194.37 12586.20 7275.50 72.99
Equity 908.10 906.50 0.18 908.10 906.50 0.18 907.40 906.00 0.15
PBIDTM(%) -46.14 20.48 -325.31 -5.41 21.83 -124.80 19.66 21.61 -9.05

Lupin Share Price

2164.80 -13.40 (-0.62%)
20-Jan-2026 11:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1656.95
Dr. Reddys Lab 1169.00
Cipla 1390.00
Zydus Lifesciences 881.00
Lupin 2164.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×